Tumor Clinical Trials

A listing of Tumor medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 194 clinical trials
A Phase III Randomized Trial Comparing Adjuvant MK-3475 (Pembrolizumab) to Standard of Care Observation in Completely Resected Merkel Cell Carcinoma

This phase III trial studies how well pembrolizumab works compared to standard of care observation in treating patients with stage I-III Merkel cell cancer that has been completely removed by surgery.

  • 0 views
  • 19 Feb, 2024
  • 1 location
A Phase 1b/2a Multi-Center Open-Label Study to Evaluate the Safety and Efficacy of Combination Treatment with MEDI0457 (INO-3112) and Durvalumab (MEDI4736) in Patients with Recurrent/Metastatic Human Papilloma Virus Associated Head and Neck Squamous Cancer

The purpose of this research study is to measure how well and how safe MEDI0457 vaccine in combination with Durvalumab is in treating patients with recurrent/metastatic human papilloma virus associated head and neck squamous cancer.

  • 0 views
  • 19 Feb, 2024
  • 1 location
One-on-one exercise program in adolescent and young adult cancer survivors with a certified clinical cancer exercise specialist

Researchers will also study changes in the blood and body that may occur during the program by collecting samples of blood at various times during the study.Participants have been diagnosed with cancer and have completed their cancer treatment ( not including hormonal or continued maintenance treatment).

  • 0 views
  • 19 Feb, 2024
  • 1 location
Phase II trial of retroperitoneal lymph node dissection as first-line treatment for testicular seminoma with isolated retroperitoneal disease (1-2cm)

The purpose of this study is to evaluate the safety and effectiveness of Retroperitoneal Lymph Node Dissection (RPLND) as a treatment option for seminoma that has gone to the lymph nodes in the retroperitoneum.

  • 0 views
  • 19 Feb, 2024
  • 1 location
IUCRO-0031; Molecular and Pathological Correlates of Treatment Outcome in Patients with Thymoma and Thymic Carcinoma

The primary objective of this study is to obtain blood and tissue samples for laboratory evaluation.

  • 0 views
  • 19 Feb, 2024
  • 1 location
IUCRO-0498; Role of Osteocytes in Myeloma Bone Disease

The purpose of this study is to learn if substances that may cause bone destruction are increased in blood or bone marrow.

  • 0 views
  • 19 Feb, 2024
  • 1 location
Randomized Phase II Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479 NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma

This randomized phase II trial studies how well combination chemotherapy with or without ganitumab works in treating patients with newly diagnosed Ewing sarcoma that has spread to other parts of the body.

  • 0 views
  • 19 Feb, 2024
  • 1 location
Phase 2 Study of Imatinib in Children with Neurofibromatosis and Airway Tumors

The purpose of this study is to look at a subset of plexiform neurofibromas and determine if the airway tumors are more sensitive to imatinib therapy.

  • 0 views
  • 19 Feb, 2024
  • 1 location
Phase I/II Study of Ixazomib and Romidepsin in Relapsed/ Refractory Peripheral T-cell Lymphoma (PTCL)

The purpose of this study is to test the safety and efficacy of combining two drugs, ixazomib and romidepsin. It will also measure the percentage of patients whose tumor completely resolves after receiving ixazomib and romidepsin.

  • 0 views
  • 19 Feb, 2024
  • 1 location
Phase II open-label global study to evaluate the effect of dabrafenib in combination with trametinib in children and adolescent patients with BRAF V600 mutation positive Low Grade Glioma (LGG) or relapsed or refractory High Grade Glioma (HGG)

The purpose of this study is to investigate the activity of dabrafenib in combination with trametinib in children and adolescent patients with BRAF V600 mutation positive low grade glioma or relapsed or refractory high grade glioma.

  • 0 views
  • 19 Feb, 2024
  • 1 location